Competitive
Intelligence

We help clients shape disease area strategies by addressing unmet needs, optimizing development and navigating market dynamics, using market, competitive and regulatory insights to guide prioritization, differentiation and positioning.

We help clients plan indication sequencing by optimizing launch order and timing, using clinical, regulatory and market insights to prioritize opportunities and maximize impact across indications.

We build life cycle management strategies to maximize long-term asset value by identifying new opportunities for brand diversification or enhancement, while mitigating threats such as those from biosimilars or generics.

We predict competitors’ likely actions and develop strategic and tactical responses to mitigate threat or maximize opportunity in cross-functional workshops backed by real-time insights.

We help clients prepare for uncertainty by considering responses to a range of potential futures, rather than a single predicted outcome, supported by analog analysis and insights from therapeutic area specialists and SMEs.

We help develop or refine specific areas of product and portfolio strategy by assessing opportunities to maximize differentiation and achieve a competitive advantage.

We facilitate decision making across functions and geographies through real-time monitoring and timely delivery of dynamic competitor, market and stakeholder insights tailored to asset stage.

We map the competitive, regulatory and market environment to identify key players, trends and disruptors, while evaluating potential risks and vulnerabilities to inform strategic decisions and mitigate threats.

We asses competitors and their best practices and use this as a benchmark for client strategy and operations to uncover opportunities to gain competitive advantages in terms of portfolio, clinical development and commercialization.

We help shape differentiated clinical strategies and optimize endpoints, geographies and timelines via clinical analytics planning to deliver an integrated view of competitive intelligence, trial landscape insights and estimated regulatory and launch timelines.

We provide timely answers to urgent questions through ethical primary intelligence gathering by SMEs, leveraging our network of experts.

We optimize conference and meeting coverage based on pre-, peri- and post-event analytics, on-ground intelligence and real-time insights to maximize scientific, competitor and stakeholder value.